C-reactive protein co-expresses with tumor necrosis factor-α in the myocardium in human dilated cardiomyopathy
| Autor: | Yudai Shimoda, Motoyuki Nakamura, Mamoru Satoh, Ikuo Segawa, Tomonari Akatsu, Katsuhiko Hiramori |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Cardiomyopathy
Dilated Male medicine.medical_specialty Angiotensin-Converting Enzyme Inhibitors Spironolactone Proinflammatory cytokine Pathogenesis chemistry.chemical_compound Mineralocorticoid receptor Internal medicine medicine Humans cardiovascular diseases In Situ Hybridization Mineralocorticoid Receptor Antagonists biology Tumor Necrosis Factor-alpha business.industry Myocardium C-reactive protein Dilated cardiomyopathy Middle Aged medicine.disease Immunohistochemistry C-Reactive Protein Endocrinology chemistry Heart failure cardiovascular system biology.protein Female Tumor necrosis factor alpha Cardiology and Cardiovascular Medicine business Angiotensin II Type 1 Receptor Blockers |
| Zdroj: | European Journal of Heart Failure. 7:748-754 |
| ISSN: | 1388-9842 |
| Popis: | Background C-reactive protein (CRP) has recently been reported to be present in cardiac tissue and to stimulate the production of proinflammatory cytokines. Cardiac expression of tumor necrosis factor-α (TNF-α) plays an important role in the pathogenesis of dilated cardiomyopathy (DCM). Aims To determine whether CRP co-expresses with TNF-α in the myocardium and to examine its association with clinical features in patients with DCM. Methods and results Endomyocardial biopsy tissues were obtained from 41 DCM patients and 16 controls by right ventricular endomyocardial biopsy. Levels of CRP and TNF-α mRNA were measured by real-time RT-PCR. Immunohistochemistry and in situ hybridization were performed to identify the cellular sources of CRP and TNF-α. Both CRP and TNF-α mRNA were expressed in myocardium obtained from DCM patients, but not in controls. A positive correlation was found between CRP and TNF-α levels. CRP/TNF-α double staining was found to be colocalized in the cardiomyocytes of DCM patients. Both forms of mRNA were also expressed in cardiomyocytes. Both CRP and TNF-α mRNA levels were negatively correlated with systolic function and positively correlated with left ventricular volume in DCM patients. These mRNA levels were lower in DCM patients treated with a combination of spironolactone and either angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II type 1 receptor blockers (ARBs) than in patients not treated with these drugs. Conclusion Cardiac expression of CRP with TNF-α may function as a proinflammatory mediator in DCM and may be related to the clinical severity of DCM. Expression of both of these proteins was decreased in DCM patients receiving spironolactone and either ACEIs or ARBs. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|